Physician profile
Linda L Frederick
NPI 1427358530
$1,069.74
in general payments reported to CMS, 2019-2025
14 companies · $453 in 2025
The $453 reported for 2025 was more than what 78% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.45 · 2022: $59.67 · 2023: $302 · 2024: $217 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $952 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $951.62 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $326.29 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Polynovo North America LLC | $209.21 | 2025 | Novosorb Btm |
| Teleflex LLC | $188.22 | 2025 | Quikclot |
| Coloplast Corp | $70.56 | 2023 | Brava |
| Smith+Nephew, INC. | $49.12 | 2021-2024 | Grafix Pl |
| Convatec INC. | $37.07 | 2023 | |
| Bsn Medical INC | $34.54 | 2024 | |
| Davol INC. | $33.95 | 2025 | Phasix Mesh |
| Organogenesis INC. | $24.81 | 2022 | |
| Hartmann USA, INC. | $21.12 | 2025 | Zetuvit Plus 10x10 P10 |
| Medela LLC | $20.67 | 2023 | Invia Motion Endure |
| Ethicon US, LLC | $19.32 | 2021 | |
| Lemaitre Vascular, INC. | $18.62 | 2022 | |
| Paratek Pharmaceuticals, INC. | $16.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Frederick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.